Commercial RNA-based next-generation sequencing (NGS) (Ion Torrent Dx System, Thermo Fisher Scientific, Waltham, MA, USA) was performed using his resected tumor tissue as recommended by his physician, which revealed an ETV6-NTRK3 fusion. Here, NTRK3 is linked to neoplasm.